Index
1 Anti-itch Drugs Market Overview
1.1 Product Overview and Scope of Anti-itch Drugs
1.2 Anti-itch Drugs Segment by Type
1.2.1 Global Anti-itch Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Single Preparation
1.2.3 Compound Ointment
1.3 Anti-itch Drugs Segment by Application
1.3.1 Global Anti-itch Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Anti-itch Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-itch Drugs Revenue 2018-2029
1.4.2 Global Anti-itch Drugs Sales 2018-2029
1.4.3 Global Anti-itch Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-itch Drugs Market Competition by Manufacturers
2.1 Global Anti-itch Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-itch Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-itch Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Anti-itch Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-itch Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-itch Drugs, Product Type & Application
2.7 Anti-itch Drugs Market Competitive Situation and Trends
2.7.1 Anti-itch Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-itch Drugs Players Market Share by Revenue
2.7.3 Global Anti-itch Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-itch Drugs Retrospective Market Scenario by Region
3.1 Global Anti-itch Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-itch Drugs Global Anti-itch Drugs Sales by Region: 2018-2029
3.2.1 Global Anti-itch Drugs Sales by Region: 2018-2023
3.2.2 Global Anti-itch Drugs Sales by Region: 2024-2029
3.3 Global Anti-itch Drugs Global Anti-itch Drugs Revenue by Region: 2018-2029
3.3.1 Global Anti-itch Drugs Revenue by Region: 2018-2023
3.3.2 Global Anti-itch Drugs Revenue by Region: 2024-2029
3.4 North America Anti-itch Drugs Market Facts & Figures by Country
3.4.1 North America Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-itch Drugs Sales by Country (2018-2029)
3.4.3 North America Anti-itch Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-itch Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-itch Drugs Sales by Country (2018-2029)
3.5.3 Europe Anti-itch Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-itch Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-itch Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-itch Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-itch Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-itch Drugs Sales by Country (2018-2029)
3.7.3 Latin America Anti-itch Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-itch Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-itch Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-itch Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-itch Drugs Sales by Type (2018-2029)
4.1.1 Global Anti-itch Drugs Sales by Type (2018-2023)
4.1.2 Global Anti-itch Drugs Sales by Type (2024-2029)
4.1.3 Global Anti-itch Drugs Sales Market Share by Type (2018-2029)
4.2 Global Anti-itch Drugs Revenue by Type (2018-2029)
4.2.1 Global Anti-itch Drugs Revenue by Type (2018-2023)
4.2.2 Global Anti-itch Drugs Revenue by Type (2024-2029)
4.2.3 Global Anti-itch Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Anti-itch Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-itch Drugs Sales by Application (2018-2029)
5.1.1 Global Anti-itch Drugs Sales by Application (2018-2023)
5.1.2 Global Anti-itch Drugs Sales by Application (2024-2029)
5.1.3 Global Anti-itch Drugs Sales Market Share by Application (2018-2029)
5.2 Global Anti-itch Drugs Revenue by Application (2018-2029)
5.2.1 Global Anti-itch Drugs Revenue by Application (2018-2023)
5.2.2 Global Anti-itch Drugs Revenue by Application (2024-2029)
5.2.3 Global Anti-itch Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Anti-itch Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson Anti-itch Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Anti-itch Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Anti-itch Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Combe Incorporated
6.4.1 Combe Incorporated Corporation Information
6.4.2 Combe Incorporated Description and Business Overview
6.4.3 Combe Incorporated Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Combe Incorporated Anti-itch Drugs Product Portfolio
6.4.5 Combe Incorporated Recent Developments/Updates
6.5 CR SANJIU
6.5.1 CR SANJIU Corporation Information
6.5.2 CR SANJIU Description and Business Overview
6.5.3 CR SANJIU Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CR SANJIU Anti-itch Drugs Product Portfolio
6.5.5 CR SANJIU Recent Developments/Updates
6.6 Lingrui
6.6.1 Lingrui Corporation Information
6.6.2 Lingrui Description and Business Overview
6.6.3 Lingrui Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lingrui Anti-itch Drugs Product Portfolio
6.6.5 Lingrui Recent Developments/Updates
6.7 Jinyao Pharma
6.6.1 Jinyao Pharma Corporation Information
6.6.2 Jinyao Pharma Description and Business Overview
6.6.3 Jinyao Pharma Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jinyao Pharma Anti-itch Drugs Product Portfolio
6.7.5 Jinyao Pharma Recent Developments/Updates
6.8 Dinuo Pharma
6.8.1 Dinuo Pharma Corporation Information
6.8.2 Dinuo Pharma Description and Business Overview
6.8.3 Dinuo Pharma Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dinuo Pharma Anti-itch Drugs Product Portfolio
6.8.5 Dinuo Pharma Recent Developments/Updates
6.9 Huapont
6.9.1 Huapont Corporation Information
6.9.2 Huapont Description and Business Overview
6.9.3 Huapont Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huapont Anti-itch Drugs Product Portfolio
6.9.5 Huapont Recent Developments/Updates
6.10 Medimetriks Pharmaceuticals
6.10.1 Medimetriks Pharmaceuticals Corporation Information
6.10.2 Medimetriks Pharmaceuticals Description and Business Overview
6.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolio
6.10.5 Medimetriks Pharmaceuticals Recent Developments/Updates
6.11 Taro Pharmaceutical
6.11.1 Taro Pharmaceutical Corporation Information
6.11.2 Taro Pharmaceutical Anti-itch Drugs Description and Business Overview
6.11.3 Taro Pharmaceutical Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Taro Pharmaceutical Anti-itch Drugs Product Portfolio
6.11.5 Taro Pharmaceutical Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Anti-itch Drugs Description and Business Overview
6.12.3 Teva Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Teva Anti-itch Drugs Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Sun Pharmaceutical
6.13.1 Sun Pharmaceutical Corporation Information
6.13.2 Sun Pharmaceutical Anti-itch Drugs Description and Business Overview
6.13.3 Sun Pharmaceutical Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sun Pharmaceutical Anti-itch Drugs Product Portfolio
6.13.5 Sun Pharmaceutical Recent Developments/Updates
6.14 Perrigo
6.14.1 Perrigo Corporation Information
6.14.2 Perrigo Anti-itch Drugs Description and Business Overview
6.14.3 Perrigo Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Perrigo Anti-itch Drugs Product Portfolio
6.14.5 Perrigo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-itch Drugs Industry Chain Analysis
7.2 Anti-itch Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-itch Drugs Production Mode & Process
7.4 Anti-itch Drugs Sales and Marketing
7.4.1 Anti-itch Drugs Sales Channels
7.4.2 Anti-itch Drugs Distributors
7.5 Anti-itch Drugs Customers
8 Anti-itch Drugs Market Dynamics
8.1 Anti-itch Drugs Industry Trends
8.2 Anti-itch Drugs Market Drivers
8.3 Anti-itch Drugs Market Challenges
8.4 Anti-itch Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer